What is Mahamaya Lifesciences IPO?

Mahamaya Lifesciences IPO is a SME IPO. The issue is priced at ₹108-114 per equity share. The minimum order quantity is 2400 Shares. The IPO opens on 11 Nov, and closes on 13 Nov. Kfin Technologies Ltd is the registrar for the IPO. The shares are proposed to be listed on SME.

When does the Mahamaya Lifesciences IPO open and close?

The Mahamaya Lifesciences IPO opens on 11 Nov and closes on 13 Nov.

Where can I check the live subscription status of the Mahamaya Lifesciences IPO?

You can track the real-time subscription numbers using the links below: https://www.iposcanner.ai/ipo/mahamaya-lifesciences-ipo?tab=subscription

What is the issue size of the Mahamaya Lifesciences IPO?

The size of Mahamaya Lifesciences IPO is Total 61,78,800 shares(aggregating up to ₹70.44 crore) : #Fresh Issue : 56,38,800 shares(aggregating up to ₹64.28 crore) + #OFS : 5,40,000 shares(aggregating up to ₹6.16 crore).

What is the price band of the Mahamaya Lifesciences IPO?

The Mahamaya Lifesciences IPO price band is set between ₹108-114 per equity share.

What is the minimum investment for the Mahamaya Lifesciences IPO?

The minimum investment for the Mahamaya Lifesciences IPO is ₹273600.

What is the allotment date of the Mahamaya Lifesciences IPO?

The share allotment date of Mahamaya Lifesciences IPO is 14 Nov.

What is the Mahamaya Lifesciences IPO listing date?

The Mahamaya Lifesciences IPO will be listed on 18 Nov.

How to check Mahamaya Lifesciences IPO allotment status online?

Follow the steps to check the Mahamaya Lifesciences IPO allotment status online here: https://www.iposcanner.ai/ipo/mahamaya-lifesciences-ipo?tab=allotment

Who is the registrar for the Mahamaya Lifesciences IPO?

The registrar for the Mahamaya Lifesciences IPO is Kfin Technologies Ltd. You can check your allotment status on their official website.

Mahamaya Lifesciences IPO Details, GMP, Subscription & Allotment

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO Calendar GMP Tracker Subscription Status Allotment Status

IPOs

All IPOs Live IPOs Upcoming IPOs Closed IPOs Listed IPOs

Resources

eBooks

Company

Home About Us Privacy Policy Terms of Service

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

Want to stay updated?Subscribe to our newsletter

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO Calendar GMP Tracker Subscription Status Allotment Status

IPOs

All IPOs Live IPOs Upcoming IPOs Closed IPOs Listed IPOs

Resources

eBooks

Company

Home About Us Privacy Policy Terms of Service

About IPO Scanner

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Want to stay updated?Subscribe to our newsletter

About Mahamaya Lifesciences

.read-more-text__content { display: block !important; overflow: visible !important; -webkit-line-clamp: unset !important; -webkit-box-orient: initial !important; } .read-more-text__toggle { display: none !important; }

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity.The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs.The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.

Checklist Quality Analysis

Revenue Growth

Live IPOs

Sotefin Bharat

SME

Open Close16th Jul 2026 - 20th Jul 2026

Issue Size89.76 Cr

Min. Qty600 Shares

Issue Price₹ 178.00

Live IPO

Caliber Mining & Logistics

Mainboard

Open Close17th Jul 2026 - 21st Jul 2026

Issue Size450.00 Cr

Min. Qty35 Shares

Issue Price₹ 402.00

Live IPO

Companies Name	Open - Close	Issue Size	Min. Qty	Issue Price	Apply
Sotefin Bharat SME	16th Jul 2026 - 20th Jul 2026	89.76 Cr	600 Shares	₹ 178.00
Caliber Mining & Logistics Mainboard	17th Jul 2026 - 21st Jul 2026	450.00 Cr	35 Shares	₹ 402.00

See All Live IPOs

Min Investment

₹273600

Lot Size

2400 Shares

Issue Size

₹70.44 Cr

Price Range

₹108 - ₹114

Listing Date

Nov 18, 2025

IPO Doc

RHP PDF

Mahamaya Lifesciences IPO - Issue Objectives

The company will utilise ₹3.75 crore for purchasing equipment for the existing formulation plant. ₹29.42 crore will be used to establish a new manufacturing plant. The company will utilise ₹2.53 crore to construct warehouse building and purchase of machinery. The company will utilise ₹18 crore for funding working capital requirement Part of the IPO proceeds will be used for general corporate purposes

Purchase of equipment

5.83%

Capital expenditure

45.77%

Construction of warehouse building

3.94%

Working capital

28%

General corporate purposes

16.5%

Purchase of equipment

The company will utilise ₹3.75 crore for purchasing equipment for the existing formulation plant.

5.83%

Capital expenditure

₹29.42 crore will be used to establish a new manufacturing plant.

45.77%

Construction of warehouse building

The company will utilise ₹2.53 crore to construct warehouse building and purchase of machinery.

3.94%

Working capital

The company will utilise ₹18 crore for funding working capital requirement

28.00%

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes

16.50%

Financials of Mahamaya Lifesciences

In Cr.

Key Performance Indicator	30-Jun-25 (In Cr.)	31-Mar-25 (In Cr.)	31-Mar-24 (In Cr.)	31-Mar-23 (In Cr.)
Revenue	84.04	267.17	162.83	137.40
EBITDA	8.04	24.64	13.36	8.91
Expenses
Profit After Tax	4.10	12.94	5.22	3.75
Assets	218.87	188.35	112.07	77.88
Net Worth	53.50	49.42	24.66	19.44
Reserves	35.73	31.66	23.41	18.19
Borrowing	57.72	58.11	54.63	24.37

Mahamaya Lifesciences - Promoter(s)

Mahamaya Lifesciences

Krishnamurthy Ganesan Mrs

Lalitha Krishnamurthy Mr

Pre Issue Share Holding

N/A

Post Issue Share Holding

N/A

About Mahamaya Lifesciences

Checklist Quality Analysis

Live IPOs

Mahamaya Lifesciences

Mahamaya Lifesciences IPO - Issue Objectives

Purchase of equipment

Capital expenditure

Construction of warehouse building

Working capital

General corporate purposes

IPO Subscription Status

Financials of Mahamaya Lifesciences

Mahamaya Lifesciences - Promoter(s)

Registrar Contact Details

Mahamaya Lifesciences IPO - FAQs